From: The mid-term and long-term effects of tourniquet use in total knee arthroplasty: systematic review
Study Details | Outcome measurement tool | Mid-term outcomes | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Time point (month) | Score | p value | Time point (month) | Score | p value | |||||
Group Aa | Group Bb | Group Cc | Group Aa | Group Bb | ||||||
Ejaz, et al (2014) [12] | KOOS-Pain | 6 | 88.66 | 89.07 | Â | n.s. | 12 | 91.09 | 92.31 | n.s. |
Hasanain, et al (2018) [15] | VAS | 3 | 1.96 | 1.77 | Â | n.s. | Â | Â | Â | Â |
Huang, et al (2017) [19] | VAS ± SD | 3 | 0.64 ± 0.63 | 0.48 ± 0.50 | 0.52 ± 0.54 | n.s. |  |  |  |  |
6 | 0.40 ± 0.73 | 0.32 ± 0.47 | 0.36 ± 0.48 | n.s. |  |  |  |  | ||
Jawhar, et al (2019) [20] | WOMAC Pain ± SD | 6 | 10 ± 7.04 | 13 ± 8.97 |  | n.s. |  |  |  |  |
OKS ± SD | 6 | 25 ± 7.99 | 27 ± 8.92 |  | n.s. |  |  |  |  | |
NAS-Pain ± SD | 6 | 0.9 ± 0.2 | 1.2 ± 0.3 |  | n.s. |  |  |  |  | |
Touzopoulos, et al (2019) [48] | NKSS-symptoms ± SD |  |  |  |  |  | 36 | 19.43 ± 1.74 | 19 ± 2.12 | n.s. |
Zhou, et al (2017) [55] | HSS ± SD | 3 | 82.5 ± 4.5 | 81.6 ± 4.4 |  | n.s. |  |  |  |  |
6 | 89.8 ± 4.9 | 90.7 ± 4.5 |  | n.s. |  |  |  | |||
VAS (Thigh Pain) ± SD | 3 | 0.16 ± 0.65 | 0.16 ± 0.65 |  |  |  |  |  | ||
6 | 0.14 ± 0.62 | 0.14 ± 0.62 |  |  |  |  |  | |||
Alexandersson, et al (2018) [6] | VAS | 3 | 2.9 | 4.7 |  | < 0.05 |  |  |  |  |
Dennis, et al (2015) [10] | NRPS ± SD | 3 | 2.56 ± 2.14 | 2.32 ± 2.07 |  | n.c. |  |  |  |  |
Rathod, et al (2014) [40] | VAS ± SD | 3 | 2.7 ± 1.9 | 2.8 ± 1.8 |  | n.s. | 12 | 0.8 ± 1.4 | 1.1 ± 1.2 | n.s. |
KSSC ± SD | 3 | 73.5 ± 11.9 | 71.4 ± 15.2 |  | n.s. | 12 | 87.9 ± 7.5 | 86.8 ± 9.1 | n.s. | |
SF-36 PCS ± SD | 3 | 40.72 ± 7.75 | 42.79 ± 8.31 |  | n.s. | 12 | 49.58 ± 7.34 | 49.55 ± 8.28 | n.s. | |
Ayik, et al (2020) [7] | VAS ± SD | 3 | 3 ± 1.3 | 3 ± 1.28 |  | n.s. |  |  |  |  |
Chaudhry, et al (2020) [9] | NPRS ± SD | 6 | 2.66 ± 018 | 2.60 ± 0.21 |  | n.s. |  |  |  |  |
VAS satisfaction ± SD | 6 | 73.05 ± 11.84 | 70.23 ± 16.85 | n.s. |